NCT00073866View on ClinicalTrials.gov

Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Lung Cancer
Interventions
DRUG

celecoxib

DRUG

docetaxel

DRUG

irinotecan hydrochloride

Trial Locations (3)

60201

Evanston Northwestern Health Care - Evanston Hospital, Evanston

60432

Silver Cross Hospital, Joliet

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00073866 - Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter